[go: up one dir, main page]

NO20013665L - Kaliumsalt av (S)-omeprazol - Google Patents

Kaliumsalt av (S)-omeprazol

Info

Publication number
NO20013665L
NO20013665L NO20013665A NO20013665A NO20013665L NO 20013665 L NO20013665 L NO 20013665L NO 20013665 A NO20013665 A NO 20013665A NO 20013665 A NO20013665 A NO 20013665A NO 20013665 L NO20013665 L NO 20013665L
Authority
NO
Norway
Prior art keywords
omeprazole
potassium salt
potassium
salt
Prior art date
Application number
NO20013665A
Other languages
English (en)
Other versions
NO319719B1 (no
NO20013665D0 (no
Inventor
Maths Nilsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20013665L publication Critical patent/NO20013665L/no
Publication of NO20013665D0 publication Critical patent/NO20013665D0/no
Publication of NO319719B1 publication Critical patent/NO319719B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20013665A 1999-01-28 2001-07-26 Kaliumsalt av (S)-omeprazol NO319719B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9900274A SE9900274D0 (sv) 1999-01-28 1999-01-28 New compound
PCT/SE2000/000087 WO2000044744A1 (en) 1999-01-28 2000-01-18 Potassium salt of ($i(s))-omeprazole

Publications (3)

Publication Number Publication Date
NO20013665L true NO20013665L (no) 2001-07-26
NO20013665D0 NO20013665D0 (no) 2001-07-26
NO319719B1 NO319719B1 (no) 2005-09-05

Family

ID=20414267

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013665A NO319719B1 (no) 1999-01-28 2001-07-26 Kaliumsalt av (S)-omeprazol

Country Status (40)

Country Link
US (1) US6511996B1 (no)
EP (1) EP1149090B1 (no)
JP (1) JP2002535401A (no)
KR (1) KR100624054B1 (no)
CN (1) CN1231477C (no)
AR (1) AR022425A1 (no)
AT (1) ATE236899T1 (no)
AU (1) AU768676B2 (no)
BG (1) BG65060B1 (no)
BR (1) BR0007647A (no)
CA (1) CA2357744C (no)
CZ (1) CZ300504B6 (no)
DE (1) DE60002042T2 (no)
DK (1) DK1149090T3 (no)
DZ (1) DZ3001A1 (no)
EE (1) EE04240B1 (no)
EG (1) EG23980A (no)
ES (1) ES2193937T3 (no)
HK (1) HK1041259B (no)
HU (1) HU226766B1 (no)
ID (1) ID30095A (no)
IL (1) IL144107A0 (no)
IS (1) IS2019B (no)
MY (1) MY119095A (no)
NO (1) NO319719B1 (no)
NZ (1) NZ512804A (no)
PL (1) PL197881B1 (no)
PT (1) PT1149090E (no)
RS (1) RS50200B (no)
RU (1) RU2237666C2 (no)
SA (1) SA00200895B1 (no)
SE (1) SE9900274D0 (no)
SI (1) SI1149090T1 (no)
SK (1) SK285626B6 (no)
TN (1) TNSN00017A1 (no)
TR (1) TR200102138T2 (no)
TW (1) TWI269795B (no)
UA (1) UA71594C2 (no)
WO (1) WO2000044744A1 (no)
ZA (1) ZA200105526B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US6875872B1 (en) * 1993-05-28 2005-04-05 Astrazeneca Compounds
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
EP1633736A1 (en) * 2003-05-05 2006-03-15 Ranbaxy Laboratories Limited Barium salt of benzimidazole derivative
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005117870A2 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
NZ551970A (en) * 2004-06-24 2010-01-29 Astrazeneca Ab New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods
ES2259269B1 (es) 2005-03-03 2007-11-01 Esteve Quimica, S.A. Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
AU2006306906B2 (en) * 2005-10-26 2010-02-04 Hanmi Science Co., Ltd. S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same
US7576219B2 (en) 2005-10-26 2009-08-18 Hanmi Pharm. Co., Ltd Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
CN100384839C (zh) * 2006-02-17 2008-04-30 中国科学院上海有机化学研究所 [(取代的吡啶基)甲基]亚磺酰基-1h-苯并咪唑类化合物及其对映体的锌盐的制备方法
US20100286208A1 (en) * 2006-06-21 2010-11-11 Bobba Venkata Siva Kumar Novel polymorph of esomeprazole potassium and process for its preparation
GB2444593B (en) 2006-10-05 2010-06-09 Santarus Inc Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
WO2008057802A2 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
PE20120395A1 (es) 2006-12-04 2012-05-23 Bayer Ip Gmbh Sal de potasio cristalina de analogos de lipoxina a4
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
WO2009074997A2 (en) * 2007-12-10 2009-06-18 Lee Pharma Ltd. A novel process for the preparation of crystalline magnesium salt of (s)-omeprazole di hydrate
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
WO2010097583A1 (en) 2009-02-24 2010-09-02 Cipla Limited Esomeprazole potassium polymorph and its preparation
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
US8895271B2 (en) 2009-12-08 2014-11-25 Codexis, Inc. Synthesis of prazole compounds
CN102319223B (zh) * 2011-09-21 2013-06-19 石药集团欧意药业有限公司 一种埃索美拉唑冻干制剂及其制备方法
CN102633776B (zh) * 2012-03-28 2014-06-18 中山市仁合药业有限公司 一种埃索美拉唑及其钠盐的制备方法
EP4598528A1 (en) 2022-10-04 2025-08-13 Arsenil Zabirnyk Inhibition of aortic valve calcification

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
GB2189698A (en) 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
US5877192A (en) 1993-05-28 1999-03-02 Astra Aktiebolag Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
ES2100142T3 (es) 1994-07-08 2002-03-01 Astrazeneca Ab Forma de dosificacion en tabletas i constituida por unidades multiples.
SE504459C2 (sv) 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
SE510666C2 (sv) 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
SE510643C2 (sv) * 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B

Also Published As

Publication number Publication date
SI1149090T1 (en) 2003-10-31
US6511996B1 (en) 2003-01-28
PT1149090E (pt) 2003-07-31
DE60002042T2 (de) 2003-12-18
HK1041259B (en) 2003-10-24
NO319719B1 (no) 2005-09-05
ATE236899T1 (de) 2003-04-15
CN1231477C (zh) 2005-12-14
UA71594C2 (uk) 2004-12-15
KR20010101699A (ko) 2001-11-14
MY119095A (en) 2005-03-31
EP1149090A1 (en) 2001-10-31
IL144107A0 (en) 2002-05-23
CZ20012730A3 (cs) 2002-02-13
TNSN00017A1 (fr) 2005-11-10
EE200100395A (et) 2002-10-15
BG65060B1 (bg) 2007-01-31
HK1041259A1 (en) 2002-07-05
BR0007647A (pt) 2001-10-16
KR100624054B1 (ko) 2006-09-18
SE9900274D0 (sv) 1999-01-28
HU226766B1 (en) 2009-09-28
TWI269795B (en) 2007-01-01
CN1339034A (zh) 2002-03-06
CZ300504B6 (cs) 2009-06-03
RS50200B (sr) 2009-07-15
EE04240B1 (et) 2004-02-16
TR200102138T2 (tr) 2001-12-21
AU2469400A (en) 2000-08-18
SK10372001A3 (sk) 2002-02-05
JP2002535401A (ja) 2002-10-22
IS2019B (is) 2005-06-15
BG105841A (en) 2002-04-30
AR022425A1 (es) 2002-09-04
DZ3001A1 (fr) 2004-03-27
CA2357744A1 (en) 2000-08-03
DK1149090T3 (da) 2003-06-30
ZA200105526B (en) 2002-10-04
AU768676B2 (en) 2003-12-18
NZ512804A (en) 2003-07-25
IS5989A (is) 2001-07-05
WO2000044744A1 (en) 2000-08-03
RU2237666C2 (ru) 2004-10-10
CA2357744C (en) 2009-06-16
HUP0105313A2 (hu) 2002-05-29
SA00200895B1 (ar) 2006-11-11
SK285626B6 (sk) 2007-05-03
ES2193937T3 (es) 2003-11-16
ID30095A (id) 2001-11-01
EG23980A (en) 2008-02-27
PL197881B1 (pl) 2008-05-30
HUP0105313A3 (en) 2003-01-28
NO20013665D0 (no) 2001-07-26
DE60002042D1 (de) 2003-05-15
YU53801A (sh) 2004-07-15
EP1149090B1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
NO20013665L (no) Kaliumsalt av (S)-omeprazol
CY2012029I1 (el) Νεα μορφη της s-ομεπραζολης
DK0975778T3 (da) Anvendelse af glyphostat-resistende majslinier
DE50007243D1 (de) Säschar
DK0991641T3 (da) Krystallinsk form af omeprazol-natriumsalt
ATE338021T1 (de) Substituierte 2-dialkylaminoalkylbiphenyl- derivate
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
ID28032A (id) TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2
ID30023A (id) Kombinasi senyawa aktif fungisida
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
EE200100381A (et) Morfolinobensamiidi uued soolad
PT1175417E (pt) Compostos substituidos de benzolactamas
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
PT1020132E (pt) Aba de puxar destacavel
NO20016030L (no) Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
NO20005856D0 (no) Anvendelse av 1,1-diokso-perhydro-1,2,4-tiadiaziner
SE9902239D0 (sv) Kornisch bestående av flera delar
NO20006392D0 (no) Anvendelse av cytoprotektive midler
SE9900032D0 (sv) Use of biocontrol agent
SE9901114D0 (sv) Reducering av Nox
FI4185U1 (fi) Savustuslaite
SE9904269D0 (sv) Use of new responsive elements
SE9903009D0 (sv) Use of new responsive elements

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees